Diagnostic utility of von Hippel-Lindau gene product, maspin, IMP3, and S100P in adenocarcinoma of the gallbladder.

No abstract is available for this paper.

• Publication year

  2013

• Venue

  Human Pathology

• Publication date

  2013-04-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1016/j.humpath.2012.06.010PMID 23079206
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Reevaluation and identification of the best immunohistochemical panel (pVHL, Maspin, S100P, IMP-3) for ductal adenocarcinoma of the pancreas.

  2012cited by this paper
• Neoplasms of the Gallbladder

  2011cited by this paper
• Glucose Transporter-1 (GLUT-1) Immunoreactivity in Benign, Premalignant and Malignant Lesions of the Gallbladder

  2011cited by this paper
• Expression of CDX2 and Hepatocyte Antigen in Benign and Malignant Lesions of Gallbladder and Its Correlation with Histopathologic Type and Clinical Outcome

  2011cited by this paper
• S100P, von Hippel-Lindau gene product, and IMP3 serve as a useful immunohistochemical panel in the diagnosis of adenocarcinoma on endoscopic bile duct biopsy.

  2010cited by this paper
• Cell adhesion molecules P-cadherin and CD24 are markers for carcinoma and dysplasia in the biliary tract.

  2010cited by this paper
• Expression of the GLUT1 glucose transporter and p53 in carcinomas of the pancreatobiliary tract.

  2010cited by this paper
• Aberrant maspin expression is involved in early carcinogenesis of gallbladder cancer

  2010cited by this paper
• Expression of p16 protein in gallbladder carcinoma and its precancerous conditions.

  2010cited by this paper
• The expression of matrix metalloproteinases in intrahepatic cholangiocarcinoma, hilar (Klatskin tumor), middle and distal extrahepatic cholangiocarcinoma, gallbladder cancer, and ampullary carcinoma: role of matrix metalloproteinases in tumor progression and prognosis.

  2009cited by this paper
• Prediction of prognosis in gallbladder carcinoma by CD147 and MMP-2 immunohistochemistry

  2009cited by this paper
• Claudin-1, −2, −3, −4, −7, −8, and −10 Protein Expression in Biliary Tract Cancers

  2009cited by this paper
• Reg IV expression and clinicopathologic features of gallbladder carcinoma.

  2009cited by this paper
• N-cadherin serves as diagnostic biomarker in intrahepatic and perihilar cholangiocarcinomas

  2009cited by this paper
• Immunohistochemical detection of the von Hippel-Lindau gene product (pVHL) in human tissues and tumors: a useful marker for metastatic renal cell carcinoma and clear cell carcinoma of the ovary and uterus.

  2008cited by this paper
• Expression of epithelial cell adhesion molecule in gallbladder carcinoma and its correlation with clinicopathologic variables.

  2008cited by this paper
• Diagnostic Utility of S100P and von Hippel-Lindau Gene Product (pVHL) in Pancreatic Adenocarcinoma—With Implication of Their Roles in Early Tumorigenesis

  2008cited by this paper
• Usefulness of S100P in diagnosis of adenocarcinoma of pancreas on fine-needle aspiration biopsy specimens.

  2008cited by this paper
• EGFR Expression in Gallbladder Carcinoma in North America

  2008cited by this paper
• Aberrant maspin expression in gallbladder epithelium is associated with intestinal metaplasia in patients with cholelithiasis

  2006cited by this paper
• Carcinoma of the gallbladder. Histologic types, stage of disease, grade, and survival rates

  1992cited by this paper
• Carcinoma of the extrahepatic bile ducts. Histologic types, stage of disease, grade, and survival rates

  1992cited by this paper
• Pathology of the gallbladder

  1984cited by this paper

• The paradoxical role of SERPINB5 in gastrointestinal cancers: oncogene or tumor suppressor?

  2025cites this paper
• Utility of IMP3, p53, and S100P immunohistochemical stains in distinguishing reactive atypia from dysplasia in cholecystectomy specimens

  2024cites this paper
• Ancillary Tests for Hepatobiliary Neoplasms: What We Know and What We Need to Know.

  2023cites this paper
• Gallbladder carcinomas: Review and updates on morphology, immunohistochemistry and staging.

  2022cites this paper
• Gallbladder Cancer with Biliary Intraepithelial Neoplasia Complicated by Pancreaticobiliary Maljunction: A Case Report.

  2022cites this paper
• Current Pathology Model of Pancreatic Cancer

  2022cites this paper
• S100P as a marker for poor survival and advanced stage in gallbladder carcinoma.

  2021cites this paper
• Intraoperative Evaluation of the Liver, Extrahepatic Bile Ducts, Gallbladder, and Pancreas

  2021cites this paper
• Diagnostic accuracy of combined MUC5A, S100P, and von Hippel-Lindau in differentiating intrahepatic cholangiocarcinoma from metastatic pancreaticobiliary carcinomas presented as hepatic focal lesions

  2021cites this paper
• Expression of Insulin-like Growth Factor II mRNA-binding Protein 3 in Gallbladder Carcinoma

  2020cites this paper
• Subcellular expression of maspin – from normal tissue to tumor cells

  2019cites this paper
• Mutational profiling and immunohistochemical analysis of a surgical series of ampullary carcinomas

  2019cites this paper
• Pancreas and Biliary Tract

  2018cites this paper
• IMP2/IGF2BP2 expression, but not IMP1 and IMP3, predicts poor outcome in patients and high tumor growth rate in xenograft models of gallbladder cancer

  2017cites this paper
• The Evolving Role of Pathology in New Developments, Classification, Terminology, and Diagnosis of Pancreatobiliary Neoplasms.

  2017cites this paper
• Practical Immunohistochemistry in Neoplastic Pathology of the Gastrointestinal Tract, Liver, Biliary Tract, and Pancreas.

  2017cites this paper
• Genetic alterations in Japanese extrahepatic biliary tract cancer.

  2017cites this paper
• IMP3 overexpression occurs in various important cancer types and is linked to aggressive tumor features: A tissue microarray study on 8,877 human cancers and normal tissues

  2017cites this paper
• Aberrant Maspin mRNA Expression is Associated with Clinical Outcome in Patients with Pulmonary Adenocarcinoma

  2016cites this paper
• IMPs: an RNA-binding protein family that provides a link between stem cell maintenance in normal development and cancer

  2016cites this paper
• The life and works of S100P - from conception to cancer.

  2016cites this paper
• Adenocarcinoma of the Gallbladder (Classical Gallbladder Cancer)

  2016cites this paper
• SERPINB5 Promoter Hypomethylation Differentiates Pancreatic Ductal Adenocarcinoma From Pancreatitis

  2016cites this paper
• Carcinoma of the Gallbladder: Current State and Future Directions in Diagnosis and Treatment

  2016cites this paper
• Utility of immunohistochemistry in the pancreatobiliary tract.

  2015cites this paper
• An immunohistochemical marker panel including claudin-18, maspin, and p53 improves diagnostic accuracy of bile duct neoplasms in surgical and presurgical biopsy specimens

  2015cites this paper
• Gallbladder Cancer: Approaches to Biomarker Discovery

  2015cites this paper
• Diagnostic value of maspin in distinguishing adenocarcinoma from benign biliary epithelium on endoscopic bile duct biopsy.

  2015cites this paper
• Oncofetal Protein IMP3, a New Cancer Biomarker

  2014cites this paper
• The role of the oncofetal IGF2 mRNA-binding protein 3 (IGF2BP3) in cancer.

  2014cites this paper
• Immunohistochemical distinction between intrahepatic cholangiocarcinoma and pancreatic ductal adenocarcinoma.

  2014cites this paper
• Seminars in Cancer Biology

  year unknowncites this paper